LMP-1 gene therapy (Sofamor)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLMP-1 gene therapy (Sofamor)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionLatent membrane protein 1 modulators
TargetsLatent membrane protein 1
Therapy Area/IndicationsFractures, Bone
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedtronic Sofamor Danek
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedtronic Sofamor Danek
Active IndicationsN/A
Inactive IndicationsFractures, Bone

Other Information

ATC CodeN/A
Related LinksN/A